Sunitinib malate and sorafenib may be beneficial at the treatment of advanced bladder cancer due to their anti-angiogenic effects.
Med Hypotheses. 2007;69(4):892-5. doi: 10.1016/j.mehy.2007.01.065. Epub 2007 Mar 26.
Med Hypotheses. 2007.
PMID: 17368754